To improve pain management and patient outcomes thereby reducing unnecessary exposures and preventing substance use disorders

  • Reexamining approval standards and strengthening post market review
  • Incentivizing and supporting alternative pain therapies and technologies
  • Promoting appropriate use and disposal of medications with misuse potential

United States Government Partners

  • Department of Health & Human Services (HHS)
  • Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)
  • National Institutes of Health (NIH)
  • Substance Abuse and Mental Health Services Administration (SAMHSA)

FDA Activities

Related Meetings